Phase II Study of Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial.

Trial Profile

Phase II Study of Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Jul 2009

At a glance

  • Drugs Bevacizumab (Primary) ; Capecitabine; Oxaliplatin
  • Indications Rectal cancer
  • Focus Therapeutic Use
  • Acronyms A-CORRECT
  • Most Recent Events

    • 21 Jul 2009 Actual end date (May 2009) added as reported by ClinicalTrials.gov.
    • 21 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 21 Jul 2009 Planned number of patients changed from 55 to 43 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top